GLP-1 Receptor Agonist
Wegovy®(Semaglutide)
The Proven GLP-1 for Weight Loss
Wegovy® (semaglutide) is FDA-approved for chronic weight management—the same medication as Ozempic at higher doses optimized specifically for weight loss.
Avg weight loss
15-17%
vs retail
87%
up to 87% savings vs ~$1350/mo retail
Frequency
Once Weekly
Most patients start at $275/mo. Some starting options are as low as $149/mo. Final pricing is set with your provider during your consultation.
How Wegovy works
Wegovy mimics the GLP-1 hormone your body naturally produces after eating. It works on the brain to reduce appetite and increase feelings of fullness, while also slowing stomach emptying. This creates a powerful combination that helps you eat less without feeling deprived.
Clinical evidence: In the STEP trials, patients taking Wegovy lost an average of 15-17% of their body weight over 68 weeks—roughly 35 pounds for the average participant.
Benefits at PWL
- FDA-approved specifically for weight loss
- Proven 15-17% average body weight reduction
- Established safety profile with years of data
- Once-weekly convenient injection
- Significant appetite and craving reduction
- Cardiovascular benefits (reduced heart attack/stroke risk)
- Improvement in blood pressure and cholesterol
- Well-studied with extensive clinical trial data
Common side effects
- Nausea (usually improves by week 4-8)
- Diarrhea or vomiting
- Constipation
- Abdominal pain
- Headache or fatigue
Side effects are typically mild and improve over time. Your provider will guide you on managing any symptoms during your monthly check-ins.